Sign up for Table of Contents Alerts.
Email this page
Print this page
Brief Communication
Palladin is Overexpressed in the Non-neoplastic Stroma of Infiltrating Ductal Adenocarcinomas of the Pancreas, but is only Rarely Overexpressed in Neoplastic Cells
Safia N. Salaria, Peter Illei, Rajni Sharma, Kimberly M. Walter, Alison Klein, James R. Eshleman, Anirban Maitra, Richard Schulick, Jordan Winter, Michel M. Ouellette, Michael Goggins and Ralph Hruban
volume 6 | issue 3
March 2007Pages: 324 - 328
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Background: It has recently been suggested that over expression of palladin in sporadic pancreatic cancer may contribute to pancreatic cancer’s invasive and migratory abilities. This hypothesis was based on reverse transcriptase-polymerase chain reaction analyses of bulk pancreatic tissue, yet pancreatic cancer is a complex admixture of neoplastic epithelial cells and desmoplastic stroma.
Design: Immunohistochemical labeling of tissue microarrays was used to define the patterns of palladin protein expression in 177 ductal adenocarcinomas of the pancreas. Western blot analysis was used to determine the epitope(s) of palladin recognized by the antibody as well as the relative levels of palladin expression in short-term cultures of stromal fibroblasts, non-neoplastic ductal cells and pancreatic cancer cell lines.
Results: Immunolabeling revealed that the palladin protein was strongly over expressed in non-neoplastic stromal cells in 171 (96.6%) of the 177 evaluable pancreatic cancers. By contrast, the over expression of palladin protein by the neoplastic epithelial cells relative to normal pancreatic epithelium was observed in only 22 (12.4%) of the 177 cancers. Western blot analysis confirmed that the antibody recognizes the ~90 kDa isoform of palladin, and demonstrated that fibroblast cell lines had higher expression of palladin than pancreatic cancer cell lines.
Conclusions: The over expression of palladin relative to normal pancreas in the majority of pancreatic cancers is limited to non-neoplastic stromal cells. This observation highlights the limitations of relying on bulk tissues when analyzing gene expression. Since palladin is not over expressed in most pancreatic cancer cells, the over expression of palladin is not likely to be responsible for pancreatic cancer cells invasive and migratory abilities.
Authors
Safia N. Salaria
Johns Hopkins University, Baltimore, Maryland
Peter Illei
Johns Hopkins University, Baltimore, Maryland
Rajni Sharma
Johns Hopkins University, Baltimore, Maryland
Kimberly M. Walter
Johns Hopkins University, Baltimore, Maryland
Alison Klein
Johns Hopkins University, Baltimore, Maryland
James R. Eshleman
Johns Hopkins University, Baltimore, Maryland
Anirban Maitra
Johns Hopkins University, Baltimore, Maryland
Richard Schulick
Johns Hopkins University, Baltimore, Maryland
Jordan Winter
Johns Hopkins University, Baltimore, Maryland
Michel M. Ouellette
The University of Nebraska Medical Center, NE
Michael Goggins
The Sol Goldman Center for Pancreatic Cancer Research
Ralph Hruban
The Sol Goldman Center for Pancreatic Cancer Research
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.